Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Genome sequencing of the bloody clam, Scapharca (Anadara) broughtonii

PROVIDER: PRJNA521075 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8535390_subreads.fastq.gz	Fastqsanger.gz
	SRR8535400_subreads.fastq.gz	Fastqsanger.gz
	SRR8535391_subreads.fastq.gz	Fastqsanger.gz
	SRR8535401_subreads.fastq.gz	Fastqsanger.gz
	SRR8535392_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 20

Similar Datasets

Anadara broughtonii

Project description:Anadara broughtonii Genome sequencing

| PRJNA263440 | ENA

Anadara broughtonii

Project description:Scapharca broughtonii overview

| PRJNA194271 | ENA

Project description:Transcriptomic sequencing of Scapharca broughtonii

| PRJNA450478 | ENA

Project description:Transcriptome sequencing of Scapharca broughtonii

| PRJNA600150 | ENA

Anadara broughtonii

Project description:Scapharca broughtonii Raw sequence reads

| PRJNA353663 | ENA

Anadara broughtonii

Project description:Anadara broughtonii Transcriptome or Gene expression

| PRJNA329570 | ENA

Project description:Transcriptomic sequencing of Scapharca broughtonii infecting with Ostreid herpesvirus 1

| PRJNA628528 | ENA

Project description:Small RNA sequencing of Scapharca broughtonii challenged with Ostreid herpesvirus 1

| PRJNA668611 | ENA

Project description:PacBio transcriptomic sequencing of Scapharca broughtonii infected with Ostreid herpesvirus 1

| PRJNA628527 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data